The European & Developing Countries Clinical Trials Partnership (EDCTP) funds clinical research to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria as well as other poverty-related infectious diseases in sub-Saharan Africa, with a focus on phase II and III clinical trials.
Video on EDCTP
A short animated video explaining the EDCTP programme’s Why, What and How in 210 seconds.
Find it on the EDCTP YouTube channel Edctpmedia.
EDCTP 2003-2018
Overview of selected EDCTP-funded clinical studies for medical interventions against poverty-related infectious diseases, 2003-2018. To date, EDCTP has achieved significant success in bringing together researchers and institutions in Europe and Africa, conducting clinical research and developing research capacity in sub-Saharan Africa.
Europe & Africa
EDCTP is one of the EU’s flagship programmes, contributing towards the European Research Area in multiple ways.
EDCTP delivers added value for countries and organisations in sub-Saharan Africa.
Latest news
WANECAM consortium kicks off clinical study for next-generation antimalarial drug
The West African Network for Clinical Trials of Antimalarial Drugs (WANECAM), a consortium of ten academic organisations in Africa and Europe, starts off the ‘WANECAM 2’ study in Bamako, Mali with a meeting on 15 April 2019. EDCTP invests EUR…
World TB Day: EDCTP investments in TB research rise to EUR 127 million
World Tuberculosis Day on 24 March 2019 is themed ‘It’s time’. As the World Health Organisation (WHO) explains, the theme underlines “the urgency to act” on the commitments made by global leaders in September 2018. At the United Nations TB…